TECNALIA and LABSAN showcase their CDMO services at CPHI 2026, the leading international pharmaceutical industry event
Pharmaceutical development and contract manufacturing at the world’s largest event for the pharmaceutical and biopharmaceutical sectors
TECNALIA and LABSAN will be exhibiting at CPHI 2026 (Milan), the leading international event for the pharmaceutical and biopharmaceutical industries.
The trade fair will bring together the sector’s key players in areas such as active ingredients, machinery, packaging and services. It will be held at Fiera Milano (Italy) between October 6 and 8, 2026, with more than 62,000 professionals and 2,400 exhibitors expected to attend from all over the world.
TECNALIA: innovation and excellence in CDMO services
TECNALIA has a strong track record in the pharmaceutical sector and will showcase its capabilities in the areas of pharmaceutical development and contract manufacturing, consolidating its position as a Contract Development and Manufacturing Organisation (CDMO). This focus on being a CDMO drives innovation, scientific progress and the discovery of solutions that help improve the quality of life for people around the world.
Pharmaceutical (galenic and analytical) development services
Our pharmaceutical development laboratories offer a wide range of services focused on developing and optimising drugs:
- Galenic development of solid, liquid and semi-solid drugs
- 3D printing processes for drugs
- Development and validation of analytical methods
- Quality control of pharmaceutical products
- Stability studies and product analysis and release
State-of-the-art pharmaceutical manufacturing
Our manufacturing plant, Labsan, provides advanced contract manufacturing services, covering the entire industrial development cycle:
- Batches for clinical research
- Pilot and regulatory batches
- Commercial batches
These capabilities mean that we can support our customers from the laboratory stage right up to launch on the global market, ensuring quality, scalability and regulatory compliance.
Commitment to the pharmaceutical industry
TECNALIA understands the importance of building strong, lasting relationships. Our commitment is focused on driving the development of the pharmaceutical sector through innovative solutions and CDMO services, thereby actively contributing to scientific and technological progress.
Visit us at Stand 12P66
If you would like to find out more about our CDMO services and explore opportunities for working together, we would be delighted to talk to you at the trade fair.
If you prefer, you can contact us today and book an appointment with our experts.
- Francisco Ledo, Head of Business Development at Pharma Labs TECNALIA
- Eider Larrarte, Director of Pharma Labs TECNALIA